TC-F2
TC-F2 is a reversible non-covalent binding inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 28 nM. FAAH is involved in many human diseases, particularly cancer, pain and inflammation as well as neurological, metabolic and cardiovascular disorders[1].
Product Specifications
CAS Number
1304778-15-1
UNSPSC
12352005
Target
FAAH
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Inflammation/Immunology; Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/tc-f2.html
Purity
99.35
Solubility
DMSO : 250 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1N([C@]2([H])CN(C3=NC=CC(C4=CC5=CC=CC=C5O4)=N3)CCC2)C6=CC=CC=C6N1CC
Molecular Formula
C26H25N5O2
Molecular Weight
439.51
References & Citations
[1]Florian M Dato, et al. Characterization of fatty acid amide hydrolase activity by a fluorescence-based assay. Anal Biochem. 2018 Apr 1;546:50-57.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3017), CF405S conjugate, 0.1mg/mL
IKB alpha (NFKBIA) pSer32/36 Rabbit Polyclonal Antibody
Recombinant Human EphB2 Protein (aa 570-987, His &GST Tag)
Tyrosinase (Melanoma Marker) (TYR/2024R), CF488A conjugate, 0.1mg/mL
